biotech
Bio-AnalystSupplement research
person

Creatine

Selected research topic

Exercise performance

Findings differ across measurements or study conditions. The results below keep them separate.

Some findings concern patients or people with a deficiency.

Publications for this topic
17
Human comparison publications
3
Publications needing review
10

Findings in the studies

  • mean power output

    • A better result than the comparison group was reported.
      General population · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: Creatine monohydrate versus placebo during repeated-sprint testing
      Additional measurement information
      Primary outcome
      Measurement time
      After supplementation before repeated-sprint test
  • peak anaerobic cycling power

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • peak and mean power output during repeated sprints

    • No clear difference from the comparison group was found.
      General population · Single ingredient · 7 days
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups. · Study comparison: creatine monohydrate versus placebo
      Additional measurement information
      Primary outcome
      Measurement time
      7 days
  • Outcome needs clarification

    About this measure

    Original outcome name: AMP

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Creatine-alone across trials; abstract does not report direct placebo contrast for AMP
      Additional measurement information
      Primary outcome
      Measurement time
      four-day loading; post-supplementation
Other measured outcomes (3)
  • PPO

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient · After 14 days
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · General population
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Study comparison: Within-arm pre/post increase reported for creatine but not placebo; direct between-group PPO estimat
      Additional measurement information
      Primary outcome
      Measurement time
      After 14 days
  • SPPB scores

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient · baseline to week 8
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Changes within the same group were compared. · Within-group comparison
      Additional measurement information
      Primary outcome
      Measurement time
      baseline to week 8
  • performance enhancement

    Research with unclear study subject or type
    • Results for this measurement were mixed; no consistent conclusion can be drawn.
      varied trial periods
      Measurement and study conditions
      Study type
      Systematic review
      Study population
      Recorded population category: General population. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Results were compared between groups. · Study comparison: alternative creatine forms versus placebo; only three trials directly compared with creatine monohyd
      Measurement time
      varied trial periods

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (8)
  • ABK performance · Distinct papers needing additional review: 1Direction unclear: 1
  • aerobic power achieved at W8 · Distinct papers needing additional review: 1Evidence criteria check: 1
  • Exercise performance · Distinct papers needing additional review: 1Direction unclear: 1
  • Jumping performance · Distinct papers needing additional review: 1Evidence criteria check: 1
  • lean mass · Distinct papers needing additional review: 1Evidence criteria check: 1
  • maximum weight lifted · Distinct papers needing additional review: 1Evidence criteria check: 1
  • strength · Distinct papers needing additional review: 1Evidence criteria check: 1
  • TBW · Distinct papers needing additional review: 1Evidence criteria check: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Human studies reported a within-group change in AMP.

Single-ingredient studies · Human studies · within-group comparison

1 publications linked to this result

  • Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 65.2 evidence score includes 9 independent human studies and 9 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 77

Papers linked to this topic 17 · distinct papers 17 · papers with a confirmed human comparison 3 · papers needing additional review 10

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • ABK performance: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • aerobic power achieved at W8: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • AMP: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Exercise performance: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Jumping performance: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • lean mass: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • maximum weight lifted: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • mean power output: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • peak anaerobic cycling power: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • peak and mean power output during repeated sprints: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • performance enhancement: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • PPO: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • SPPB scores: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • strength: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • TBW: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

peak and mean power output during repeated sprints

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

AMP

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

mean power output

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

peak anaerobic cycling power

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

PPO

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

performance enhancement

Results for this measurement were mixed; no consistent conclusion can be drawn.

Review · Unknown intervention · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

SPPB scores

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

ABK performance

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

aerobic power achieved at W8

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Jumping performance

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

lean mass

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

maximum weight lifted

The study needs further checking before its result can be interpreted.

Meta-analysis · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

strength

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TBW

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No reviewed caution rules are available yet. Reported caution findings are shown below.

Review 3 combination findings and 0 findings that outperformed an ingredient alone.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Gastrointestinal symptoms and muscle cramping1 papers
Creatine monohydrate was well tolerated but gastrointestinal symptoms and muscle cramping were reported as possibly related adverse events.Human studies · Randomized controlled trial

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

HMBCombined supplementation of HMB and Creatine monohydrate showed a synergistic effect on aerobic power at W8, W4, and WAT compared to the sum of effects from single supplements.
탄산수소나트륨Combined creatine and sodium bicarbonate supplementation significantly improved 30-m sprint and arrowhead agility performance in elite soccer players compared to placebo.
D-리보스A double-blind RCT in 53 patients with ischemic heart disease found that a combination supplement containing D-ribose, creatine, and vitamins improved cardiac double product and exercise tolerance compared to placebo, though the authors note the surrogate measure requires further validation.